Healx Limited

Royaume‑Uni

Commandez votre montre hebdomadaire Healx Limited
Quantité totale PI 37
Rang # Quantité totale PI 39 059
Note d'activité PI 2,3/5.0    25
Rang # Activité PI 31 500
Classe Nice dominante Services scientifiques, technolo...

Brevets

Marques

7 1
4 0
22 3
0
 
Dernier brevet 2025 - Sabizabulin for use in the treat...
Premier brevet 2016 - Tricyclic dibenzothiazepine type...
Dernière marque 2020 - HEALX
Première marque 2020 - HEALX

Industrie (Classification de Nice)

Derniers inventions, produits et services

2024 Invention Sabizabulin for use in the treatment of polycystic kidney disease. The present invention relates ...
Invention Sulindac and/or sulindac sulfide for the treatment of angelman syndrome. The present invention re...
2023 Invention Nitroxoline for use in the treatment or prevention of a malignant peripheral nerve sheath tumour....
Invention Polymorph of the ketoglutarate or p-toleunesulphonate salt of mebendazole. The present invention ...
Invention Ibudilast and gaboxadol for the treatment of fragile x syndrome. tt thereof; and • (ii) ibudilast...
2022 Invention Nitroxoline for use in the treatment or prevention of a plexiform neurofibroma. The present inven...
Invention Kit, composition, and combination therapy for fragile x syndrome. Described herein are kits, com...
Invention Nitroxoline for use in the treatment of cutaneous neurofibroma. The present invention relates to...
Invention Nitroxoline for use in the treatment of cutaneous neurofibroma. The present invention relates to ...
Invention Lovastatin for use in the treatment of neuroblastoma. The present invention relates to compositio...
Invention Prochlorperazine for use in the treatment of neuroblastoma. The present invention relates to comp...
Invention Trifluoperazine for use in the treatment of neurobéastoma. The present invention relates to compo...
2021 Invention Mebendazole for use in the treatment of autosomal dominant polycystic kidney disease or autosomal...
Invention Composition for treatment of fragile x syndrome. The present invention relates to compositions an...
2020 Invention Treatment of fragile x syndrome with ibudilast in combination with metformin, cannbidiol, sertral...
Invention Treatment of fragile x syndrome. The present invention relates to a composition comprising ibudi...
Invention Treatment of fragile x syndrome. The present invention relates to a composition comprising ibudil...
Invention Treatment of pitt-hopkins syndrome. The present invention relates to compositions and kits compri...
Invention Minocycline for the treatment of pitt-hopkins syndrome. The present invention relates to minocyc...
Invention Treatment of pitt-hopkins syndrome. The present invention relates to amitriptyline or a pharmace...
Invention Treatment of pitt-hopkins syndrome. The present invention relates to amitriptyline or a pharmaceu...
Invention Prochlorperazine for the treatment of pitt-hopkins syndrome. The present invention relates to pro...
Invention Minocycline for the treatment of pitt-hopkins syndrome. The present invention relates to minocycl...
P/S Pharmaceutical drugs; drugs for medical purposes; medicines for human purposes; all of the goods ...
P/S Pharmaceutical drugs; drugs for medical purposes; medicines for human purposes. Scientific and t...
P/S Scientific and technological services and research and design relating thereto; industrial analy...
2019 Invention Tricyclic dibenzothiazepine type compounds for use in the therapy of cdkl5 disorder. Tricyclic d...
Invention Treatment of fragile x syndrome. Described herein is the use of sulindac in the treatment of frag...
Invention Treatment of fragile x syndrome. The present invention relates to sulindac, or a pharmaceutically...
Invention Kit, composition, and combination therapy for fragile x syndrome. Described herein are kits, comp...
Invention Kit, composition and combination therapy for fragile x syndrome. The present invention relates to...
2016 Invention Biomarker signatures predictive of drug response. A method of prognosing the response of a patien...
Invention Tricyclic dibenzothiazepine type compounds for use in the therapy of cdkl5 disorder. Tricyclic di...